Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

5.5%

45 terminated/withdrawn out of 816 trials

Success Rate

86.8%

+0.3% vs industry average

Late-Stage Pipeline

17%

139 trials in Phase 3/4

Results Transparency

18 of 295 completed trials have results

Key Signals

188 recruiting18 with results37 terminated8 withdrawn

Enrollment Performance

Analytics

N/A

285(54.4%)

Phase 4

79(15.1%)

Phase 2

65(12.4%)

Phase 3

60(11.5%)

Phase 1

33(6.3%)

Early Phase 1

2(0.4%)

524Total

N/A(285)

Phase 4(79)

Phase 2(65)

Phase 3(60)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (816)

Showing 20 of 816 trials

NCT05841095Phase 1Active Not Recruiting

Evaluation of the Novel Therapeutic Hepatitis B Virus Synthetic Long Peptide Vaccination ISA104

Role: lead

NCT07634081Recruiting

Validation of SDS-EDTA-Treated Chromatography Paper Strips for Mpox Sampling and Transport in DRC

Role: collaborator

NCT07636837Not ApplicableCompleted

Efficiency Provision Process Assistive Devices for Donning and Doffing Compression Hosiery

Role: collaborator

NCT07188025Phase 3Recruiting

ctDNA-Based Adjuvant Chemotherapy for High-Risk Rectal Cancer

Role: lead

NCT07631767Not ApplicableNot Yet Recruiting

Shift Workers' Health Behavior Action Program Across Europe

Role: collaborator

NCT07629661Not ApplicableActive Not Recruiting

Effectiveness and Implementation of a Clinical Pain Management Dashboard for the NICU

Role: lead

NCT06414200Not ApplicableRecruiting

Nutritional Care After Discharge in Children Term Born-18years Old

Role: lead

NCT05186064Not ApplicableCompleted

Glioblastoma Targeted Treatment Option Maximization by WGS

Role: collaborator

NCT07624786Not Yet Recruiting

Patient-Ventilator Asynchrony: Occurence and Clinical Impact in Usual Care

Role: lead

NCT07133490Phase 2Recruiting

INTERACT Stomach-II

Role: lead

NCT07497724Active Not Recruiting

Odevixibat Outcomes in Patients With PFIC Versus an External Control Cohort (OvEC-PFIC)

Role: collaborator

NCT06883448Not ApplicableRecruiting

Implementation of Home Monitoring in Patients With Pulmonary Fibrosis

Role: lead

NCT05546372Not ApplicableRecruiting

Endobiliary Radiofrequency Ablation for Malignant Biliary Obstruction Due to Perihilar Cholangiocarcinoma

Role: collaborator

NCT07594054Not Yet Recruiting

Inflammation Digital Biomarkers Validation Study

Role: collaborator

NCT04489173Phase 2Completed

TAS102 in Patients With ER-positive, HER2-negative Advanced Breast Cancer

Role: collaborator

NCT07592624Not ApplicableNot Yet Recruiting

Evaluation of an Instructional Video About Medication Management During Admission and Medication Adherence for Kidney Transplantation and in the Outpatient Clinic in a Dutch University Hospital.

Role: lead

NCT04927780Phase 3Active Not Recruiting

Perioperative or Adjuvant mFOLFIRINOX for Resectable Pancreatic Cancer

Role: lead

NCT07556887Not ApplicableRecruiting

Clinical Impact of Using IMPROVE to Select Patients for Carotid Revascularisation

Role: collaborator

NCT07241715Phase 2Active Not Recruiting

Conversion Surgery for Gastric Cancer With Peritoneal Metastases (CONVERGENCE)

Role: collaborator

NCT07587918Not ApplicableNot Yet Recruiting

Sweet & Sour: Dietary Acid Load in Type 2 Diabetes and Kidney Disease Across Sex and Ethnic Groups

Role: lead